AIM
XENT

Assured Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Assured Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,830
Closed -$477K – 993
2019
Q1 		$477K Sell
14,830
-5,753
-28% -$178K 0.01% 598
2018
Q4 		$580K Buy
20,583
+7,830
+61% +$229K 0.02% 606
2018
Q3 		$367K Sell
12,753
-12,226
-49% -$367K 0.01% 852
2018
Q2 		$935K Buy
24,979
+19,936
+395% +$783K 0.02% 583
2018
Q1 		$198K Buy
+5,043
New +$184K ﹤0.01% 977

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Assured Investment Management's XENT Position: Q2 2019 in Review

Assured Investment Management sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 14,830 shares — an estimated $477K sold.

Assured Investment Management first reported a position in XENT in Q1 2018 and held it in 5 quarters. The position peaked at $935K in Q2 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • Assured Investment Management reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 14,830 Intersect ENT, Inc shares in Q2 2019, an estimated $477K.
  • Assured Investment Management first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Intersect ENT, Inc position peaked at $935K in Q2 2018.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.